244 related articles for article (PubMed ID: 32696762)
1. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
[TBL] [Abstract][Full Text] [Related]
2. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
[TBL] [Abstract][Full Text] [Related]
3. Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.
Sun W; Li L; Du Z; Quan Z; Yuan M; Cheng H; Gao Y; Luo C; Wu X
Oncol Rep; 2019 May; 41(5):2689-2702. PubMed ID: 30864728
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
Liu J; Quan Z; Gao Y; Wu X; Zheng Y
Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
[TBL] [Abstract][Full Text] [Related]
6. PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor.
Wang Y; Wu X; Ou L; Yang X; Wang X; Tang M; Chen E; Luo C
Cancer Lett; 2015 Jun; 362(1):61-9. PubMed ID: 25796442
[TBL] [Abstract][Full Text] [Related]
7. Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR.
Hsieh PF; Jiang WP; Basavaraj P; Huang SY; Ruangsai P; Wu JB; Huang GJ; Huang WC
Phytomedicine; 2021 Dec; 93():153806. PubMed ID: 34740154
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
9. PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis.
Pu J; Li T; Liu N; Luo C; Quan Z; Li L; Wu X
Oncol Rep; 2020 May; 43(5):1397-1412. PubMed ID: 32323799
[TBL] [Abstract][Full Text] [Related]
10. PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis.
Cheng H; Hao Y; Gao Y; He Y; Luo C; Sun W; Yuan M; Wu X
Oncol Rep; 2019 May; 41(5):2844-2854. PubMed ID: 30864733
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
[TBL] [Abstract][Full Text] [Related]
13. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
14. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation.
Ling Y; Chunli L; Xiaohou W; Qiaoling Z
Cell Biol Int; 2011 Oct; 35(10):1031-6. PubMed ID: 21121899
[TBL] [Abstract][Full Text] [Related]
16. shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo.
Cheng H; Luo C; Wu X; Zhang Y; He Y; Wu Q; Xia Y; Zhang J
Urology; 2011 Aug; 78(2):474.e7-11. PubMed ID: 21705050
[TBL] [Abstract][Full Text] [Related]
17. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
18. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
19. Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation.
Sodi VL; Bacigalupa ZA; Ferrer CM; Lee JV; Gocal WA; Mukhopadhyay D; Wellen KE; Ivan M; Reginato MJ
Oncogene; 2018 Feb; 37(7):924-934. PubMed ID: 29059153
[TBL] [Abstract][Full Text] [Related]
20. PLCε regulates metabolism and metastasis signaling via HIF-1α/MEK/ERK pathway in prostate cancer.
Fan Y; Ou L; Fan J; Li L; Wang X; Niu L; Wu X; Luo C
J Cell Physiol; 2020 Nov; 235(11):8546-8557. PubMed ID: 32383180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
